These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 2528779)

  • 1. An evaluation of the elevated plus-maze test using the novel anxiolytic buspirone.
    Moser PC
    Psychopharmacology (Berl); 1989; 99(1):48-53. PubMed ID: 2528779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the elevated plus-maze the anxiolytic-like effects of the 5-HT(1A) agonist, 8-OH-DPAT, but not the anxiogenic-like effects of the 5-HT(1A) partial agonist, buspirone, are blocked by the 5-HT1A antagonist, WAY 100635.
    Collinson N; Dawson GR
    Psychopharmacology (Berl); 1997 Jul; 132(1):35-43. PubMed ID: 9272757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepam.
    Moser PC; Tricklebank MD; Middlemiss DN; Mir AK; Hibert MF; Fozard JR
    Br J Pharmacol; 1990 Feb; 99(2):343-9. PubMed ID: 1970269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: II. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties.
    Millan MJ; Hjorth S; Samanin R; Schreiber R; Jaffard R; De Ladonchamps B; Veiga S; Goument B; Peglion JL; Spedding M; Brocco M
    J Pharmacol Exp Ther; 1997 Jul; 282(1):148-61. PubMed ID: 9223550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone.
    Griebel G; Perrault G; Sanger DJ
    Psychopharmacology (Berl); 1998 Jul; 138(1):55-66. PubMed ID: 9694527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 5-HT1A receptor agonists and L-5-HTP in Montgomery's conflict test.
    Söderpalm B; Hjorth S; Engel JA
    Pharmacol Biochem Behav; 1989 Jan; 32(1):259-65. PubMed ID: 2567524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actions and some interactions of 5-HT1A ligands in the elevated X-maze and effects of dorsal raphe lesions.
    Critchley MA; Njung'e K; Handley SL
    Psychopharmacology (Berl); 1992; 106(4):484-90. PubMed ID: 1533721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
    de Boer SF; Lesourd M; Mocaer E; Koolhaas JM
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral buspirone causes a shift in the dose-response curve between the elevated-plus maze and Vogel conflict tests in Long-Evans rats: relation of brain levels of buspirone and 1-PP to anxiolytic action.
    Vaidya AH; Rosenthal DI; Lang W; Crooke JJ; Benjamin D; Ilyin SE; Reitz AB
    Methods Find Exp Clin Pharmacol; 2005 May; 27(4):245-55. PubMed ID: 16082425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of inflammatory nociception on the anxiolytic-like effect of diazepam and buspirone in rats.
    Fernández-Guasti A; Reyes R; Martínez-Mota L; López-Muñoz FJ
    Psychopharmacology (Berl); 2005 Jul; 180(3):399-407. PubMed ID: 15719217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Behavioral pharmacological and electroencephalographic effects of the 5-HT1A partial agonist ipsapirone].
    Yamamoto T; Shibata S; Teshima K; Inoue Y; Ushio M; Tominaga K; Ohno M; Watanabe S; Ueki S
    Nihon Yakurigaku Zasshi; 1991 Jul; 98(1):41-52. PubMed ID: 1679740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleus incertus contributes to an anxiogenic effect of buspirone in rats: Involvement of 5-HT1A receptors.
    Kumar JR; Rajkumar R; Lee LC; Dawe GS
    Neuropharmacology; 2016 Nov; 110(Pt A):1-14. PubMed ID: 27436722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative behavioural profiles of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine (1-PP) in the murine elevated plus-maze.
    Cao BJ; Rodgers RJ
    Neuropharmacology; 1997 Aug; 36(8):1089-97. PubMed ID: 9294974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.
    Harada K; Aota M; Inoue T; Matsuda R; Mihara T; Yamaji T; Ishibashi K; Matsuoka N
    Eur J Pharmacol; 2006 Dec; 553(1-3):171-84. PubMed ID: 17074317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of acute and chronic treatment of various serotonergic agents with those of diazepam and idazoxan in the rat elevated X-maze.
    Wright IK; Heaton M; Upton N; Marsden CA
    Psychopharmacology (Berl); 1992; 107(2-3):405-14. PubMed ID: 1352058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiogenic behavior in rats during acute and protracted ethanol withdrawal: reversal by buspirone.
    Lal H; Prather PL; Rezazadeh SM
    Alcohol; 1991; 8(6):467-71. PubMed ID: 1781924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buspirone, ipsapirone and 1-(2-pyrimidinyl)-piperazine decrease cold-induced thyrotropin secretion in rats.
    Broqua P; Baudrie V; Bluet-Pajot MT; Chaouloff F
    Eur J Pharmacol; 1991 Nov; 204(2):141-7. PubMed ID: 1687218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT ipsapirone and buspirone in the rat.
    Schreiber R; De Vry J
    Eur J Pharmacol; 1993 Nov; 249(3):341-51. PubMed ID: 7904566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1-(2-pyrimidinyl)-piperazine may alter the effects of the 5-HT1A agonist in the learned helplessness paradigm in rats.
    Martin P
    Psychopharmacology (Berl); 1991; 104(2):275-8. PubMed ID: 1678895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained 5-hydroxytryptamine release-inhibitory and anxiolytic-like action of the partial 5-HT1A receptor agonist, buspirone, after prolonged chronic administration.
    Söderpalm B; Lundin B; Hjorth S
    Eur J Pharmacol; 1993 Aug; 239(1-3):69-73. PubMed ID: 7901030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.